KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $3.8 billion.

  • Biogen's Cash & Current Investments rose 6066.11% to $3.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.8 billion, marking a year-over-year increase of 6066.11%. This contributed to the annual value of $3.8 billion for FY2025, which is 6066.11% up from last year.
  • Biogen's Cash & Current Investments amounted to $3.8 billion in Q4 2025, which was up 6066.11% from $4.0 billion recorded in Q3 2025.
  • In the past 5 years, Biogen's Cash & Current Investments ranged from a high of $6.1 billion in Q2 2023 and a low of $1.0 billion during Q4 2023
  • In the last 5 years, Biogen's Cash & Current Investments had a median value of $3.0 billion in 2021 and averaged $3.3 billion.
  • In the last 5 years, Biogen's Cash & Current Investments crashed by 7868.8% in 2024 and then surged by 14183.73% in 2025.
  • Over the past 5 years, Biogen's Cash & Current Investments (Quarter) stood at $3.8 billion in 2021, then rose by 28.67% to $4.9 billion in 2022, then plummeted by 78.54% to $1.0 billion in 2023, then soared by 126.21% to $2.4 billion in 2024, then surged by 60.66% to $3.8 billion in 2025.
  • Its last three reported values are $3.8 billion in Q4 2025, $4.0 billion for Q3 2025, and $2.8 billion during Q2 2025.